By Will Feuer

Johnson & Johnson issued new financial results for previous quarters that strip out the consumer-health unit that was recently separated into a new company called Kenvue.

J&J, which is now focused on its pharmaceutical and medical-technology businesses, said second-quarter sales were $21.52 billion, up 6.5% from a year ago.

Last month, the company reported second-quarter sales of $25.53 billion, which included the consumer-health business.

J&J also said Wednesday that second-quarter adjusted earnings from continuing operations were $2.56 without the consumer-health business, down from the $2.80 a share that the company had reported last month.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

August 30, 2023 07:15 ET (11:15 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Kenvue (NYSE:KVUE)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Kenvue.
Kenvue (NYSE:KVUE)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Kenvue.